Colchicine Tablets

DRUG14 trials

Sponsors

Mutual Pharmaceutical Company, Inc., Hillel Yaffe Medical Center, Kaohsiung Medical University Chung-Ho Memorial Hospital, University of Copenhagen, Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Conditions

Acute Coronary SyndromeAtrial FibrillationCOVID-19COVID19Cholangiocarcinoma, IntrahepaticCholangiocarcinoma; With Hepatocellular CarcinomaColchicineColchicine Mechanism of Action

Phase 1

Pharmacokinetic Study of an Acute Gout Regimen

CompletedNCT01017042

Mutual Pharmaceutical Company, Inc.Pharmacokinetics

Start: 2007-09-30End: 2007-10-31Updated: 2009-11-20

Pharmacokinetic Study With Colchicine in Healthy Volunteers

CompletedNCT01017003

Mutual Pharmaceutical Company, Inc.Pharmacokinetics

Start: 2007-09-30End: 2007-12-31Updated: 2009-11-20

Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine

Brigham and Women's HospitalColchicine Mechanism of Action

Start: 2020-05-06End: 2023-04-30Target: 18Updated: 2022-03-16

Phase 2

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

CompletedNCT04264260

Kaohsiung Medical University Chung-Ho Memorial HospitalCholangiocarcinoma, Intrahepatic, Cholangiocarcinoma; With Hepatocellular Carcinoma, Hepatocellular Carcinoma Stage IIIB +1

Start: 2019-12-24End: 2025-05-30Updated: 2025-09-08

Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)

CompletedNCT04355143

University of California, Los AngelesCOVID-19

Start: 2020-05-01End: 2021-07-21Updated: 2022-11-03

The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection

CompletedNCT04360980

Shahid Beheshti University of Medical SciencesCOVID-19

Start: 2020-03-20End: 2021-01-30Updated: 2022-01-28

Phase 3

Trial to Study the Benefit of Colchicine in Patients With COVID-19

CompletedNCT04350320

Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaCOVID19

Start: 2020-04-30End: 2020-12-30Updated: 2021-01-12

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19

TerminatedNCT04516941

Insel Gruppe AG, University Hospital BernCOVID-19, SARS-CoV Infection

Start: 2021-01-21End: 2022-08-31Updated: 2022-09-08

The Effect of Colchicine on Inflammation in ACS Patients

CompletedNCT06054100

Ain Shams UniversityAcute Coronary Syndrome, STEMI

Start: 2020-02-01End: 2022-05-20Updated: 2023-09-26

Role of Colchicine as Anti-Inflammatory Therapy in HFpEF

Active, not recruitingNCT06837623

Cairo UniversityHFpEF - Heart Failure With Preserved Ejection Fraction

Start: 2024-07-01End: 2025-03-01Target: 75Updated: 2025-02-25

Unknown Phase

Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels

Hillel Yaffe Medical CenterAtrial Fibrillation

Start: 2019-11-30End: 2022-11-30Target: 300Updated: 2019-11-07

Repurposing Colchicine to Improve Vascular Function in Hypertension

CompletedNCT04303689

University of CopenhagenEssential Hypertension

Start: 2020-08-01End: 2023-02-28Updated: 2023-05-10

Colchicine Has Anti-diabetic Effect

CompletedNCT04377321

Ministry of Health and Population, EgyptTreatment Adherence

Start: 2019-10-10End: 2020-05-02Updated: 2020-05-06

Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19

Shanghai Public Health Clinical CenterColchicine, Covid19

Start: 2021-09-06End: 2023-09-01Target: 60Updated: 2021-09-09

Related Papers

Phase <scp>IIb</scp> Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

The Kaohsiung Journal of Medical Sciences2025-09-27

Colchicine effect on biomarkers of cardiac remodelling and atherosclerosis in ST‐elevation myocardial infarction: A randomized controlled trial

British Journal of Clinical Pharmacology2024-10-025 citations

Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial

Journal of Cardiovascular Medicine2023-11-032 citations

FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

Clinical Drug Investigation2022-09-293 citations

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

2022-06-3043 citations

Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19

Frontiers in Cardiovascular Medicine2022-06-175 citations

Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)

International Journal of General Medicine2021-09-0132 citations

Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.

2020-06-057 citations